Sandra E. Reznik
Impact in
- Obstetrics and Gynecology top 5%
- Pregnancy and preeclampsia studies
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
- Epidemiology 27
- Preterm Birth and Chorioamnionitis 24
-
- Pregnancy and preeclampsia studies 7
- Co-authors
- Lloyd D. Fricker (6 shared papers)Charles R. Ashby (20 shared papers)Jagadish Koya (7 shared papers)Adrian R. Pierotti (1 shared paper)Marian Orłowski (1 shared paper)Ketan R. Patel (7 shared papers)Manali Patki (4 shared papers)Yue Feng (1 shared paper)
- Journals
- American Journal Of Pathology (5 papers)Placenta (4 papers)Scientific Reports (3 papers)Pharmaceutics (3 papers)American Journal of Obstetrics and Gynecology (3 papers)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Sandra E. Reznik
76 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 95
- Obstetrics and Gynecology 102
- Pharmaceutical Science 71
- Cancer Research 112
- Epidemiology 243
- Oncology 157
Countries citing papers authored by Sandra E. Reznik
This map shows the geographic impact of Sandra E. Reznik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra E. Reznik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra E. Reznik more than expected).
Fields of papers citing papers by Sandra E. Reznik
This network shows the impact of papers produced by Sandra E. Reznik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra E. Reznik. The network helps show where Sandra E. Reznik may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra E. Reznik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 141 | |
| 2 | 1989 | 107 | |
| 3 | 2021 | 80 | |
| 4 | 2018 | 60 | |
| 5 | 2018 | 54 | |
| 6 | 2021 | 52 | |
| 7 | 2010 | 46 | |
| 8 | 2001 | 43 | |
| 9 | 2003 | 32 | |
| 10 | 2000 | 30 | |
| 11 | 2011 | 30 | |
| 12 | 2016 | 30 | |
| 13 | 2013 | 28 | |
| 14 | 2019 | 28 | |
| 15 | 2002 | 27 | |
| 16 | 2012 | 27 | |
| 17 | 2012 | 26 | |
| 18 | 2019 | 26 | |
| 19 | 2020 | 26 | |
| 20 | 2014 | 23 |
About Sandra E. Reznik
Sandra E. Reznik is a scholar working on Epidemiology, Obstetrics and Gynecology, Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Cancer Research, having authored 79 papers that have together received 1.4k indexed citations. Recurring topics across this work include Preterm Birth and Chorioamnionitis (24 papers), Pregnancy and preeclampsia studies (7 papers), Advanced Drug Delivery Systems (4 papers), Protease and Inhibitor Mechanisms (4 papers), Peptidase Inhibition and Analysis (4 papers), Neuropeptides and Animal Physiology (4 papers), Birth, Development, and Health (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). The work is most often cited by research in Obstetrics and Gynecology (102 citations), Pharmaceutical Science (71 citations), Cancer Research (112 citations), Epidemiology (243 citations) and Oncology (157 citations). Sandra E. Reznik has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Lloyd D. Fricker, Charles R. Ashby, Jagadish Koya, Adrian R. Pierotti, Marian Orłowski, Ketan R. Patel, Manali Patki, Yue Feng, Maureen J. Charron and Swapna Munnangi. Their work appears in journals such as American Journal Of Pathology, Placenta, Scientific Reports, Pharmaceutics and American Journal of Obstetrics and Gynecology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.